Furthermore, FXR inhibits the activation of hepatic stellate cells by modulating the activity of the NOD-like receptor protein 3 (NLRP3) inflammasome, thus impeding the molecular progression of liver fibrosis [105,106]. The gene discussed is NR1H4; the disease is Hepatic fibrosis.